Arrowhead Stock Valuation

ARWR
 Stock
  

USD 33.05  0.23  0.69%   

How much is Arrowhead Pharma worth today? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Arrowhead Pharma, is its stock price multiplied by the total number of shares outstanding, calculating Arrowhead Pharma's enterprise value requires a different approach. It uses Arrowhead Pharma's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Arrowhead Pharma shows a prevailing Real Value of $48.05 per share. The current price of the firm is $33.05. At this time, the firm appears to be undervalued. Our model approximates the value of Arrowhead Pharma from analyzing the firm fundamentals such as Current Valuation of 4.12 B, profit margin of (42.44) %, and Return On Equity of (24.91) % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor buying undervalued instruments and selling overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
  
Arrowhead Pharma Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Arrowhead Pharma's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Undervalued
Today 33.05
Please note that Arrowhead Pharma's price fluctuation is very steady at this time. Calculation of the real value of Arrowhead Pharma is based on 3 months time horizon. Increasing Arrowhead Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Arrowhead Pharma is useful when determining the fair value of the Arrowhead stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Arrowhead Pharma. Since Arrowhead Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Arrowhead Stock. However, Arrowhead Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
48.05
Real Value
51.55
Upside
Estimating the potential upside or downside of Arrowhead Pharma helps investors to forecast how Arrowhead stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Arrowhead Pharma more accurately as focusing exclusively on Arrowhead Pharma's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
29.1436.8144.48
Details
Hype
Prediction
LowEstimated ValueHigh
29.7833.2836.78
Details
Naive
Forecast
LowNext ValueHigh
29.9233.4236.92
Details
7 Analysts
Consensus
LowTarget PriceHigh
45.0089.50106.00
Details

Arrowhead Pharma Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Arrowhead Pharma's current stock value. Our valuation model uses many indicators to compare Arrowhead Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Arrowhead Pharma competition to find correlations between indicators driving Arrowhead Pharma's intrinsic value. More Info.
Arrowhead Pharma is number one stock in price to earning category among related companies. It is number one stock in price to sales category among related companies fabricating about  0.03  of Price to Sales per Price to Earning. The ratio of Price to Earning to Price to Sales for Arrowhead Pharma is roughly  36.80 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Arrowhead Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Arrowhead Pharma's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Arrowhead Pharma's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Arrowhead Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Arrowhead Pharma and how it compares across the competition.

About Arrowhead Pharma Valuation

The stock valuation mechanism determines the current worth of Arrowhead Pharma on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Arrowhead Pharma. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Arrowhead Pharma based exclusively on its fundamental and basic technical indicators. By analyzing Arrowhead Pharma's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Arrowhead Pharma's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Arrowhead Pharma. We calculate exposure to Arrowhead Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Arrowhead Pharma's related companies.
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Arrowhead Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Pasadena, California. Arrowhead Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 329 people.

Arrowhead Pharma Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Arrowhead Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio2.90
Revenue Growth362.70%
Enterprise Value To Ebitda-37.86
Enterprise Value To Revenue15.64
Please continue to Trending Equities. You can also try Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for analysis

When running Arrowhead Pharma price analysis, check to measure Arrowhead Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharma is operating at the current time. Most of Arrowhead Pharma's value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Arrowhead Pharma's price. Additionally, you may evaluate how the addition of Arrowhead Pharma to your portfolios can decrease your overall portfolio volatility.
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Is Arrowhead Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arrowhead Pharma. If investors know Arrowhead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arrowhead Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Arrowhead Pharma is measured differently than its book value, which is the value of Arrowhead that is recorded on the company's balance sheet. Investors also form their own opinion of Arrowhead Pharma's value that differs from its market value or its book value, called intrinsic value, which is Arrowhead Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arrowhead Pharma's market value can be influenced by many factors that don't directly affect Arrowhead Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arrowhead Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Arrowhead Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arrowhead Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.